Genotropin 12 MG cartridges
Ended Awarded Last action
- Contract number
- SPE2DR26FZ93P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,515
Award facts
- Contract value 100% obligated
- $37,514.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $37,514.63 delivery order to AmerisourceBergen Drug Corp for Genotropin 12 mg cartridges, effective December 10, 2025, with an ultimate completion date of December 11, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The contract represents a child order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical.
This delivery order falls under AmerisourceBergen Drug Corp's existing prime IDC with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Genotropin is a human growth hormone treatment, and this procurement supports the Defense Health Agency and other government healthcare systems requiring specialized pharmaceutical commodities. The contract demonstrates AmerisourceBergen Drug Corp's continued capability to meet federal procurement requirements through open competition and deliver critical medical supplies to the Department of Defense supply chain.
Quick answers
Who was awarded contract SPE2DR26FZ93P?
SPE2DR26FZ93P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FZ93P worth?
The government has obligated $37,515 on SPE2DR26FZ93P.
Is contract SPE2DR26FZ93P an order under another contract?
Yes. SPE2DR26FZ93P is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ93P competed?
The extent of competition for SPE2DR26FZ93P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award